The cardiovascular devices market, especially those utilizing biomaterials, is seeing notable growth, driven by the rising incidence of cardiovascular diseases (CVDs), an aging population, and technological advancements. According to a report by Fortune Business Insights, the market is projected to reach around $60.3 billion by 2027, registering a CAGR of 6.4% from 2020. The development of innovative biomaterials for devices like stents, heart valves, and pacemakers are key growth stimulators. Nevertheless, the high cost of devices and stringent regulatory policies may restrict growth. Future market expansion is anticipated through the advent of bioresorbable stents and novel biomaterials.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
